Authors
Pierre Sonveaux, Frédérique Végran, Thies Schroeder, Melanie C Wergin, Julien Verrax, Zahid N Rabbani, Christophe J De Saedeleer, Kelly M Kennedy, Caroline Diepart, Bénédicte F Jordan, Michael J Kelley, Bernard Gallez, Miriam L Wahl, Olivier Feron, Mark W Dewhirst
Publication date
2008/12/1
Journal
The Journal of clinical investigation
Volume
118
Issue
12
Pages
3930-3942
Publisher
American Society for Clinical Investigation
Description
Tumors contain oxygenated and hypoxic regions, so the tumor cell population is heterogeneous. Hypoxic tumor cells primarily use glucose for glycolytic energy production and release lactic acid, creating a lactate gradient that mirrors the oxygen gradient in the tumor. By contrast, oxygenated tumor cells have been thought to primarily use glucose for oxidative energy production. Although lactate is generally considered a waste product, we now show that it is a prominent substrate that fuels the oxidative metabolism of oxygenated tumor cells. There is therefore a symbiosis in which glycolytic and oxidative tumor cells mutually regulate their access to energy metabolites. We identified monocarboxylate transporter 1 (MCT1) as the prominent path for lactate uptake by a human cervix squamous carcinoma cell line that preferentially utilized lactate for oxidative metabolism. Inhibiting MCT1 with α-cyano-4 …
Total citations
20092010201120122013201420152016201720182019202020212022202320242564709711014413414312714513117618813713958
Scholar articles
P Sonveaux, F Végran, T Schroeder, MC Wergin… - The Journal of clinical investigation, 2008